Skip to Main Content

In 2021, funding for health technology companies went on a tear and by July, a rush of mega-deals over $100 million had pushed the total investment to a record-breaking level. The headline from Rock Health’s mid-year funding report said it all: “Another blockbuster year…in six months.”

Things have changed, but investors cautioned that it’s not as bad as it looks.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment